Aquestive Therapeutics Stock (NASDAQ: AQST) stock price, news, charts, stock research, profile.
You can purchase shares of Aquestive Therapeutics (NASDAQ:AQST) through any online brokerage.
Other companies in Aquestive Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD), Zevra Therapeutics (NASDAQ:ZVRA) and GH Research (NASDAQ:GHRS).
Aquestive Therapeutics has a consensus price target of $9.85.
The stock price for Aquestive Therapeutics (NASDAQ: AQST) is $3.56 last updated December 24, 2024 at 4:05 PM EST.
There are no upcoming dividends for Aquestive Therapeutics.
Aquestive Therapeutics’s Q4 earnings are confirmed for Tuesday, March 4, 2025.
There is no upcoming split for Aquestive Therapeutics.
Aquestive Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.